Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine with or without sufentanil for prevention of emergence agitation in children after tonsillectomy/adenoidectomy
ChiCTR-IIR-17010413Phase 4Recruiting
- Sponsor
- The 2nd Affiliated Hospital of Harbin Medical University
- Start
- Jan 2017
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of dexmedetomidine and sufentanil in Emergence agitation (EA) (4 arms), sponsored by The 2nd Affiliated Hospital of Harbin Medical University. Primary endpoints: heart rate, mean arterial pressure and 4 more. Started Jan 2017; status: recruiting.
02
Drugs
dexmedetomidinesufentanil
03
Conditions
Emergence agitation (EA)
Beyond the preview
Go deeper on ChiCTR-IIR-17010413.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IIR-17010413.